Darmiyan

Darmiyan's revolutionary new technology and fully automated software platform can precisely locate and quantify micro-abnormalities in the brain, providing a more reliable tool for the early diagnosis of neurodegenerative diseases, while reducing the cost and time for early Alzheimer's diagnosis. Darmiyan aims to create a non-invasive, affordable, precise, and globally accessible real-time brain monitoring tool for the early detection, monitoring, and stratification of Alzheimer's disease (AD) and other neurodegenerative conditions through innovative magnetic resonance (MR) image analysis technology. Based on over 40 years of cutting-edge brain research, our technology enables precise quantification and detection of changes in brain tissue at the cellular level within each voxel (3D pixel) of a brain MRI scan.